ClearView Healthcare Partners

ClearView conducts a variety of rare disease projects, most of which highlight the extreme unmet need of patients due to limited treatment options and difficulty in diagnosing the disease due to lack of awareness. Select projects delve into the patient / caregiver’s perspective for living with (or caring for someone with) a rare disease, to fully understand the impact of the disease. This May, we invited all ClearView employees to a talk with Lisa Murray, an SMA Caregiver, to bring the patient voice to the forefront of our work and increase awareness of SMA.   #clearviewhcp #lifesciencesstrategy #YourFutureisinClearView #SMA #CureSMA

ClearView Healthcare Partners is excited to be sending a delegation of our leadership team to attend #ASCO24 from May 31 – June 4 in Chicago. We are looking forward to reconnecting with our friends and colleagues – please reach out if you are in town!   #clearviewhcp #lifesciencesconsulting #oncology #ASCO24 #ASCO2024 #YourFutureIsInClearView David Gilman, Stuart MacGregor, David Konciak, Charles Mathews, Austin Hubbert, Matt Pfister, Allana Sanborn, Kelsey Yardumian

GLP-1 receptor agonists are already reshaping people and healthcare systems for the management of obesity. Treatment paradigms in cardiovascular disease, sleep apnea, and MASH are set to be disrupted, but it is not all gravy; weight loss post GLP-1s is often not maintained and not everyone can tolerate their side effects.   We share our perspectives on the outlook for the space, including some of the implications for biopharma, service providers, and investors.   #clearviewhcp #lifesciencesconsulting #GLP1 #obesity #markettrends #YourFutureIsInClearView

ClearView is excited to participate in BIO 2024! We're particularly optimistic given the positive trend in private capital raises, as we start to see great science receive the funding it needs on the path to medicine.  We typically help pre-revenue innovators understand how to integrate capital deployment against organizational, clinical, and commercial strategy to really maximize the impact of new science on unmet patient needs.    If you're wrestling with these issues or others, and could benefit from a fresh perspective, be sure to reach out and let's find time now or next month in San Diego! Sam Ulin, David Gilman, Kai-Ming Pu, Slater Hurst #ClearViewhcp #lifesciencesstrategyconsulting #BIO2024 #YourFutureisinClearView

We are hiring in our London office, if you are currently in life sciences consulting and looking to make a change check out our new opportunities and apply directly. #lifesciencesstrategy #YourFutureisinClearView #clearviewhcp #hiring #experiencedconsultingUK https://lnkd.in/emErpBfv

At ClearView giving back to our communities is a key driver of our culture, one of our long-standing relationships is with an organization called Common Denominator, where our employees can volunteer to be a middle school tutor. Below is a testimonial from one of our many volunteer tutors at CV. #givingback #clearviewhcp #YourFutureisinClearView #commondenominator #EmpowerYouth #lifesciencesstrategy

Congratulations KKR, Impilo, and Immedica Pharma AB on your new partnership. Cheers to accelerated growth! #clearviewhcp #PE #lifesciencesstrategy https://lnkd.in/ebxFi3RP

We recently had the pleasure of partnering with Moelis & Company to host industry leaders from Private Equity and CDMOs to discuss GLP-1 Winners and Losers, considering the breadth of potential clinical benefits, sustainability of weight loss, patient access, and the long-term implications for multiple players across biopharma and pharma services. Dean Griffiths PhD Brian Quinn Sam Ulin Matt Pfister Alec M. Arek Kurkciyan Francois Saint-Lo Michael Aiello Bruno Brandao Dennis Crandall #clearviewhcp #lifesciencesconsulting #moelis #privateequity #GLP1 #obesity #YourFutureisinClearView

An exciting week at ClearView, we welcomed our first new hire cohort of 2024! While working hard in orientation and training they were able to take some time out for fun and networking with their new colleagues. Join us in welcoming our new team members in Boston, London, and San Francisco! #YourFutureisinClearView #lifesciencesconsulting #clearviewhcp #teambuilding

Join us next week, Monday, March 25th, for our final collaborative Digital Therapeutics Alliance Product Launch Meet-Up, where ClearView’s Graeme Steller will be hosting a dialogue exploring the advantages DTx and Pharma can offer one-another when developing an evidence generation strategy. #DTx #lifesciencesconsulting #clearviewhcp #YourFutureisinClearView